• Enhances Immune Function
• Provides IGF-1 & TGF A&B
• Slows Muscle Breakdown
• Improves Protein Utilization
• Contains Digestive Enzymes
• Helps Regulate Blood Sugar
• Promotes Tissue Growth and Repair

Nature's First Complete Food
COLOSTRUM is the pre-milk from select dairy herds obtained immediately after birth. Colostrum is nature's way of giving a newborn a healthy start in life and protecting it against attack from viruses, bacteria and other health threats. Increased energy, vitality, improved functioning of the GI tract, and enhanced endocrine functions are also evident in Colostrum fed calves (1).
High quality Colostrum can only be obtained in the first six hours after birth and has very low lactose levels, yet has profound biological properties (2). Certain substances in Colostrum play a major role in immune homeostasis (3). Some antibodies found in Colostrum have been shown to be useful in treating diarrhea and preventing certain E. coli infections (4). Colostrum may increase Insulin-like Growth Factor-1 (IGF-1) levels for enhanced metabolic performance.

Cows furnishing the best colostrum, they contend, eat grass and undergo no forced-feeding on feed lots. These animals, allowed to roam free in the fields, get exposure to antigens (microorganisms) so that their colostrum contains greater numbers and more varieties of antibodies.

• Lactose Free
• Bio-regulates Iron
• Supports Immune Function
• Balances Digestive Tract
• Increases Energy & Stamina
• Promotes Cell Growth & Healing

A Natural Protein from Milk
LACTOFERRIN is a lactose-free, all natural, milk protein fraction present in both human and cow's milk. Lactoferrin has a very high affinity for iron. Lactoferrin is a versatile protein that can prevent the growth of pathogenic organisms in the gut, control cell or tissue damage, and has been shown to have anti-microbial properties. Lactoferrin bio-regulates iron and provides support for functions of the immune system.

Anti-Microbial Properties:
Iron is a key mineral required by many micro-organisms for maintenance and growth. Regulation of iron by Lactoferrin in the digestive tract helps to maintain the correct balance of beneficial and harmful bacteria (5). Increased occurrence of resistance of bacteria to antibiotics suggests that it may be better to attempt to reinforce a natural means of resistance which binds free iron (6). Lactoferrin binds free iron and works with the immune system to achieve homeostasis. It is bacteriostatic by depriving harmful microorganisms of the iron they need for growth. Lactoferrin is bactericidal by direct binding to the microbial membrane, altering the membrane and leading to the death of the organism (7).
Lactoferrin delivers bound iron to beneficial bacteria and healthy cells by way of transferrin and helps maintain the current iron level by a complex biological process involving ferritin and transferrin. It decreases free, non-absorbed iron that would be otherwise available to pathogens.

Anti-Inflammatory Properties:
Lactoferrin inhibits cytokines and interleukin production after an insult to the biological mechanism (5). This reduces swelling and thus increases circulatory activity in the vicinity of the injury, which promotes healing.

• Acts as a Decoy for Cancer Cell Surface Proteins

MODIFIED CITRUS PECTIN has the potential to prevent metastasis, or the spread of cancer. The pH modified Pectin's small molecules enter the bloodstream and act as decoys for lectins (cancer cell surface proteins), which seek the sugar galactose in cells. When lectins encounter pectin, which also contains galactose, they attach to it as they would to a cell. Once bound to the pectin, lectins are unable to attach to other sites in the body in order to start new cancer colonies (8). Modified citrus pectin added to rats' drinking water has been shown to halt the spread of prostate cancer cells (9).

References:
1. Handom, et al.: "Delaying colostrum intake by one day has important effect on metabolic traits and on gastrointestinal and metabolic hormones in neonatal calves". Journal of Nutrition, Vol. 127, No. 10, pp. 2011-2023, October 1997. Vol. 127, No. 10, pp. 2011-2023, October 1997. Vol. 127, No. 10, pp. 2011-2023, October 1997.
2. Johnson, A.: "Compositions of Milk". Fundamentals of Dairy Chemistry. 2nd Edition, Avi Publishing Company, Table 1.7, p. 14, 1978 2nd Edition, Avi Publishing Company, Table 1.7, p. 14, 1978 2nd Edition, Avi Publishing Company, Table 1.7, p. 14, 1978
3. Vasseliv, et al.: "Natural polyreactive IgA and IgM autoantibodies in human colostrum". Scandinavian Journal of Immunology, Vol. 44, No. 5, Nov., pp. 535-539, November 1996. Vol. 44, No. 5, Nov., pp. 535-539, November 1996. Vol. 44, No. 5, Nov., pp. 535-539, November 1996.
4. Lissner, et al.: "A standard immunoglobulin preparation produced from bovine colostra chows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli 0157:H7". Infection,Vol. 24, No. 5, pp. 378-383, September/October 1996.Vol. 24, No. 5, pp. 378-383, September/October 1996.Vol. 24, No. 5, pp. 378-383, September/October 1996.
5. Kruzel, et al.: "The Gut: A Key Metabolic Organ Protected by Lactoferrin during Experimental Systemic Inflammation in Mice". Advances in Lactoferrin Research, Plenum Press,   pp. 167-173, 1998. Plenum Press,   pp. 167-173, 1998. Plenum Press,   pp. 167-173, 1998.
6. Ward, et al.: "Iron and Infection: New Developments and Their Implications". The Journal of Trauma, Injury, Infection and Critical Care, Journal of Trauma, Injury, Infection and Critical Care, Journal of Trauma, Injury, Infection and Critical Care, Vol. 41, No. 2, pp. 356-364, 1996.
7. Lonnerdal, et al.: "Lactoferrin and Immune Function". Lactoferrin Structure and Function, pp. 99-101, 1995. Lonnerdal, et al.: "Lactoferrin and Immune Function". Lactoferrin Structure and Function, pp. 99-101, 1995. Lonnerdal, et al.: "Lactoferrin and Immune Function". Lactoferrin Structure and Function, pp. 99-101, 1995.
8. Raloff, J.: "Jamming prostate cancer's transmission". Science News, No. 14, p. 134, 1995. Raloff, J.: "Jamming prostate cancer's transmission". Science News, No. 14, p. 134, 1995. Raloff, J.: "Jamming prostate cancer's transmission". Science News, No. 14, p. 134, 1995.
9. Pienta, KJ, et al.: "Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin". Journal Nat'l Cancer Institute, Vol. 87, No. 5, pp. 348-353, 1995 Pienta, KJ, et al.: "Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin". Journal Nat'l Cancer Institute, Vol. 87, No. 5, pp. 348-353, 1995 Pienta, KJ, et al.: "Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin". Journal Nat'l Cancer Institute, Vol. 87, No. 5, pp. 348-353, 1995
10. Georgiades, J.A.: "Oral cavity of entry into the Communication Network". Biotherapy, Vol. 11, pp. 39-51, 1998. Georgiades, J.A.: "Oral cavity of entry into the Communication Network". Biotherapy, Vol. 11, pp. 39-51, 1998. Georgiades, J.A.: "Oral cavity of entry into the Communication Network". Biotherapy, Vol. 11, pp. 39-51, 1998.